|
Report No. : |
352055 |
|
Report Date : |
02.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
EROS PHARMACEUTICALS (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
Plot No. 94, Sector 23, Korangi Industrial Area, Karachi |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1979 |
|
|
|
|
Com. Reg. No.: |
0006659 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical
Products |
|
|
|
|
No. of Employees : |
105 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Pakistan |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EROS
PHARMACEUTICALS (PRIVATE) LIMITED
|
Registered Address & Factory |
|
Plot No. 94, Sector 23, Korangi Industrial
Area, Karachi, Pakistan |
|
Tel # |
92 (21) 35073234, 35053234 |
|
Fax # |
92 (21) 35073235 |
|
Email |
|
a. |
Nature of Business |
Manufacture and Marketing of Pharmaceutical
Products |
|
b. |
Year Established |
1979 |
|
c. |
Registration # |
0006659 |
In Lahore at
present
|
S.M. Suhail & Co. (Chartered
Accountants) |
|
Subject Company was established as a Private Limited Company in 1979 |
|
Authorized Capital |
Rs. 5,000,000/- divided into 50,000 shares
of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 4,000,000/- divided into 40,000 shares
of Rs. 100/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Mohammad Iqbal Memon Mr. Khalid Akhter |
Pakistani Pakistani |
Flat No.4, Defence Garden Appartments, Block 45, Phase II, D.H.A.,
Karachi 20 - Bahadurabad, Block-K, 7/8, Shaheed-e- Millat Road, Karachi |
Business Business |
Chief Executive Director |
|
Names |
No. of Shares |
|
Mr. Mohammad Iqbal Memon Mr. Khalid Akhter |
32,000 8,000 |
A. Subsidiary
None
B. Associated Companies
(1) S.M. Ahmed &
Co, Pakistan.
(2) Iqbal Traders,
Pakistan.
Engaged
in manufacture & marketing of Pharmaceutical Products
105
The capacity and production of the company’s
plant is indeterminable as it is multi-product and involves various processes
of manufacture
|
Year |
In Pak Rupees |
|
2014 |
320,000,000/- (Estimated) |
Subject import globally from Companies belongs to China, Korea, India
& European Countries. Its global trade suppliers are Companies related to
Pharmaceutical Raw Materials
|
Mainly Government & Private Hospitals,
Pharmacies, Distribution Companies |
|
Mainly to Bangladesh, Srilanka, Iran,
Afghanistan & Middle East Countries |
|
(1) Soneri Bank Limited, Pakistan. (2) Bank Al-Habib Limited, Pakistan. (3) Faysal Bank Limited, Pakistan. (4) MCB Bank Limited, Pakistan. |
Pakistan Pharmaceutical Manufacturers
Association.(PPMA)
Karachi Chamber of Commerce & Industry.(KCCI)
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 105.90 |
|
UK Pound |
1 |
Rs. 161.50 |
|
Euro |
1 |
Rs. 113.50 |
Subject Company was established in 1979 and
is engaged in manufacture & marketing of Pharmaceutical Products. Trade
relations are reported as fair. Subject can be considered for normal business
dealings at usual trade terms and conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.52 |
|
|
1 |
Rs.100.44 |
|
Euro |
1 |
Rs.70.44 |
|
PKR |
1 |
Rs.0.63 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.